These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14615065)

  • 1. Abnormal current perception thresholds measured by neurometer among residents in blackfoot disease-hyperendemic villages in Taiwan.
    Tseng CH
    Toxicol Lett; 2003 Dec; 146(1):27-36. PubMed ID: 14615065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal peripheral microcirculation in seemingly normal subjects living in blackfoot-disease-hyperendemic villages in Taiwan.
    Tseng CH; Chong CK; Chen CJ; Lin BJ; Tai TY
    Int J Microcirc Clin Exp; 1995; 15(1):21-7. PubMed ID: 7558622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of the Neurometer in assessing diabetic neuropathy by measurement of the current perception threshold.
    Pitei DL; Watkins PJ; Stevens MJ; Edmonds ME
    Diabet Med; 1994 Nov; 11(9):872-6. PubMed ID: 7705025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan.
    Tseng CH; Chong CK; Chen CJ; Tai TY
    Atherosclerosis; 1996 Feb; 120(1-2):125-33. PubMed ID: 8645353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan.
    Tseng CH; Chong CK; Chen CJ; Tai TY
    Angiology; 1997 Apr; 48(4):321-35. PubMed ID: 9112880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
    Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM
    Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blackfoot disease and arsenic: a never-ending story.
    Tseng CH
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(1):55-74. PubMed ID: 16291522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure.
    Chen CJ; Chiou HY; Chiang MH; Lin LJ; Tai TY
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):504-10. PubMed ID: 8624771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan.
    Tseng CH; Chong CK; Tseng CP; Hsueh YM; Chiou HY; Tseng CC; Chen CJ
    Toxicol Lett; 2003 Jan; 137(1-2):15-21. PubMed ID: 12505429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
    Tseng CH
    Angiology; 2002; 53(5):529-37. PubMed ID: 12365859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis.
    Zhang NN; Wang ZY; Chen JM; Yan ZP; Ni GX; Ni J
    Curr Neurovasc Res; 2024; 21(1):41-46. PubMed ID: 38288842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of peripheral neuropathy using measurement of the current perception threshold with the neurometer in patients with type 2 diabetes mellitus.
    Matsutomo R; Takebayashi K; Aso Y
    J Int Med Res; 2005; 33(4):442-53. PubMed ID: 16104448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral sensory nerve dysfunction in children and adolescents with type 1 diabetes mellitus.
    Barkai L; Kempler P; Vámosi I; Lukács K; Marton A; Keresztes K
    Diabet Med; 1998 Mar; 15(3):228-33. PubMed ID: 9545124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients.
    Donaghue VM; Giurini JM; Rosenblum BI; Weissman PN; Veves A
    Diabetes Res Clin Pract; 1995 Jul; 29(1):37-42. PubMed ID: 8593757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of current perception threshold with the Neurometer(®) vs the Stimpod NMS450 peripheral nerve stimulator in healthy volunteers: an observational study.
    Tsui BC; Shakespeare TJ; Leung DH; Tsui JH; Corry GN
    Can J Anaesth; 2013 Aug; 60(8):753-60. PubMed ID: 23690134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease.
    Chen CJ; Wu MM; Lee SS; Wang JD; Cheng SH; Wu HY
    Arteriosclerosis; 1988; 8(5):452-60. PubMed ID: 3190552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan.
    Tseng CH
    Atherosclerosis; 2008 Jul; 199(1):12-8. PubMed ID: 18367191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system.
    Chang CC; Ho SC; Tsai SS; Yang CY
    J Toxicol Environ Health A; 2004 Sep; 67(17):1353-61. PubMed ID: 15371236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ingested inorganic arsenic and prevalence of diabetes mellitus.
    Lai MS; Hsueh YM; Chen CJ; Shyu MP; Chen SY; Kuo TL; Wu MM; Tai TY
    Am J Epidemiol; 1994 Mar; 139(5):484-92. PubMed ID: 8154472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.